Evaluation of 2LHERP in preventing recurrences of genital herpes. Institut International 3IDI.
The objective of the study was to evaluate the effectiveness of a homeopathic complex in terms of intensity of attacks and duration of remission between attacks of genital herpes. Fifty three patients aged 18 or over with a minimum of four attacks annually were followed in this open multicentre study in a primary care setting. The principal parameters analysed were: frequency of attacks; intensity of symptoms, during treatment and/or after stopping treatment; treatment tolerance. Eighty-two percent of patients treated for recurrent genital herpes benefited. In 41% of cases, there was no recurrence after the first treatment with follow-up of between 8 and 50 months. In 32% of patients, one or two relapses, in 9% of patients recurrences continued but with reduced frequency and intensity.
Jenaer
M
M
Institut International 3IDI, Paris, France.
Henry
M F
MF
Garcia
A
A
Marichal
B
B
D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D004247:DNA / Q000627:therapeutic use; D005260:Female; D006558:Herpes Genitalis / Q000517:prevention & control*; D006705:Homeopathy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010297:Paris; D055502:Secondary Prevention; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D000998:Antiviral Agents; D004247:DNA